Uterine stimulants and relaxants

Last updated: June 19, 2025

Uterine stimulants and relaxants

Revision for finals delete as I go

Revision for finals delete as I go

DNA synthesis inhibitors: Fluoroquinolones
DNA synthesis inhibitors: Metronidazole
Antimetabolites: Sulfonamides and trimethoprim
Cell wall synthesis inhibitors: Penicillins
Cell wall synthesis inhibitors: Cephalosporins
Type III hypersensitivity
Type IV hypersensitivity
Type I hypersensitivity
Type II hypersensitivity
Thymus histology
Viral structure and functions
Wound healing
Pharmacodynamics: Drug-receptor interactions
Pharmacodynamics: Agonist, partial agonist and antagonist
Somatosensory pathways
Somatosensory receptors
Ascending and descending spinal tracts
Pyramidal and extrapyramidal tracts
Nervous system anatomy and physiology
Muscle spindles and golgi tendon organs
Sciatica
Anatomy of the cranial meninges and dural venous sinuses
Anatomy of the blood supply to the brain
Anatomy of the abdominal viscera: Blood supply of the foregut, midgut and hindgut
Blood histology
Anatomy of the brainstem
Optic pathways and visual fields
Anatomy and physiology of the eye
Cerebral circulation
Stroke: Clinical
Cranial nerves
Cranial nerves rap
Cranial nerve pathways
Pharmacokinetics: Drug absorption and distribution
Anatomy of the basal ganglia
Basal ganglia: Direct and indirect pathway of movement
Cerebellum
Anatomy of the cerebellum
Auditory transduction and pathways
Vestibular transduction
Complement system
Dementia and delirium: Clinical
Substance misuse and addiction: Clinical
Tricyclic antidepressants
Typical antipsychotics
Metabolic alkalosis
Seizures and epilepsy
Free radicals and cellular injury
Traumatic brain injury: Clinical
Concussion and traumatic brain injury
Schizophrenia
Major depressive disorder
Bone remodeling and repair
Lambert-Eaton myasthenic syndrome
Pediatric orthopedic conditions: Clinical
Bone histology
Skin histology
Colon histology
Stomach histology
Cartilage histology
Ovary histology
Paget disease of bone
Non-steroidal anti-inflammatory drugs
Osteomalacia and rickets
Osgood-Schlatter disease (traction apophysitis)
Slipped capital femoral epiphysis
Developmental dysplasia of the hip
Rotator cuff tear
Thoracic outlet syndrome
Klumpke paralysis
Erb-Duchenne palsy
Carpal tunnel syndrome
Compartment syndrome
Osteomyelitis
Osteoporosis
Lordosis, kyphosis, and scoliosis
Osteoarthritis
Rheumatoid arthritis
Gout
Ankylosing spondylitis
Muscular dystrophy
Inclusion body myopathy
Dermatomyositis
Fibromyalgia
Myasthenia gravis
Opioid agonists, mixed agonist-antagonists and partial agonists
Antigout medications
Osteoporosis medications
Brachial plexus
Anatomy of the brachial plexus
Rheumatoid arthritis: Clinical
Introduction to biostatistics
Types of data
Probability
Mean, median, and mode
Range, variance, and standard deviation
Standard error of the mean (Central limit theorem)
Normal distribution and z-scores
Paired t-test
Two-sample t-test
Hypothesis testing: One-tailed and two-tailed tests
One-way ANOVA
Two-way ANOVA
Repeated measures ANOVA
Correlation
Methods of regression analysis
Linear regression
Logistic regression
Spearman's rank correlation coefficient
Mann-Whitney U test
Kappa coefficient
Chi-squared test
Fisher's exact test
Kaplan-Meier survival analysis
Type I and type II errors
Sensitivity and specificity
Positive and negative predictive value
Test precision and accuracy
Incidence and prevalence
Relative and absolute risk
Odds ratio
Attributable risk (AR)
Mortality rates and case-fatality
DALY and QALY
Direct standardization
Indirect standardization
Study designs
Ecologic study
Cross sectional study
Case-control study
Cohort study
Randomized control trial
Clinical trials
Sample size
Placebo effect and masking
Disease causality
Selection bias
Information bias
Confounding
Interaction
Bias in interpreting results of clinical studies
Bias in performing clinical studies
Prevention
Anatomy of the pelvic girdle
Anatomy of the pelvic cavity
Arteries and veins of the pelvis
Anatomy of the male reproductive organs of the pelvis
Nerves and lymphatics of the pelvis
Anatomy clinical correlates: Male pelvis and perineum
Anatomy of the breast
Anatomy of the female urogenital triangle
Anatomy clinical correlates: Breast
Development of the reproductive system
Prostate gland histology
Penis histology
Testis, ductus deferens, and seminal vesicle histology
Mammary gland histology
Fallopian tube and uterus histology
Cervix and vagina histology
Anatomy and physiology of the male reproductive system
Testosterone
Anatomy and physiology of the female reproductive system
Estrogen and progesterone
Menstrual cycle
Menopause
Pregnancy
Stages of labor
Oxytocin and prolactin
Breastfeeding
Benign prostatic hyperplasia
Prostate cancer
Erectile dysfunction
Amenorrhea
Polycystic ovary syndrome
Premature ovarian failure
Endometritis
Endometriosis
Pelvic inflammatory disease
Preeclampsia & eclampsia
Placenta previa
Placental abruption
Potter sequence
Postpartum hemorrhage
Congenital cytomegalovirus (NORD)
Miscarriage
Ectopic pregnancy
Fetal alcohol syndrome
PDE5 inhibitors
Adrenergic antagonists: Alpha blockers
Estrogens and antiestrogens
Progestins and antiprogestins
Aromatase inhibitors
Uterine stimulants and relaxants
Newborn management: Clinical
Neonatal jaundice: Clinical
Human development days 1-4
Human development days 4-7
Human development week 2
Human development week 3
Ectoderm
Mesoderm
Endoderm
Development of the placenta
Development of the fetal membranes
Development of twins
Hedgehog signaling pathway
Development of the digestive system and body cavities
Development of the umbilical cord
Development of the cardiovascular system
Fetal circulation
Blood pressure, blood flow, and resistance
Pressures in the cardiovascular system
Resistance to blood flow
Compliance of blood vessels
Microcirculation and Starling forces
Stroke volume, ejection fraction, and cardiac output
Cardiac contractility
Frank-Starling relationship
Cardiac preload
Cardiac afterload
Law of Laplace
Cardiac cycle
Cardiac work
Pressure-volume loops
Changes in pressure-volume loops
Action potentials in myocytes
Action potentials in pacemaker cells
Cardiac conduction system
Cardiac conduction velocity
ECG basics
ECG normal sinus rhythm
ECG intervals
ECG axis
ECG rate and rhythm
ECG cardiac infarction and ischemia
ECG cardiac hypertrophy and enlargement
Baroreceptors
Chemoreceptors
ACE inhibitors, ARBs and direct renin inhibitors
Calcium channel blockers
Adrenergic antagonists: Beta blockers
cGMP mediated smooth muscle vasodilators
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Miscellaneous lipid-lowering medications
Positive inotropic medications
Anatomy of the larynx and trachea
Bones and joints of the thoracic wall
Vessels and nerves of the thoracic wall
Anatomy of the lungs and tracheobronchial tree
Kidney histology
Anatomy of the diaphragm
Anatomy clinical correlates: Thoracic wall
Anatomy clinical correlates: Pleura and lungs
Development of the respiratory system
Nasal cavity and larynx histology
Trachea and bronchi histology
Bronchioles and alveoli histology
Respiratory system anatomy and physiology
Reading a chest X-ray
Lung volumes and capacities
Anatomic and physiologic dead space
Alveolar surface tension and surfactant
Ventilation
Zones of pulmonary blood flow
Regulation of pulmonary blood flow
Pulmonary shunts
Ventilation-perfusion ratios and V/Q mismatch
Airflow, pressure, and resistance
Gas exchange in the lungs, blood and tissues
Alveolar gas equation
Diffusion-limited and perfusion-limited gas exchange
Oxygen binding capacity and oxygen content
Oxygen-hemoglobin dissociation curve
Carbon dioxide transport in blood
Upper respiratory tract infection
Congenital pulmonary airway malformation
Acute respiratory distress syndrome
Emphysema
Asthma
Bronchiectasis
Chronic bronchitis
Cystic fibrosis
Alpha 1-antitrypsin deficiency
Restrictive lung diseases
Pneumonia
Pancoast tumor
Pleural effusion
Pneumothorax
Pulmonary embolism
Pulmonary edema
Pulmonary hypertension
Sleep apnea
Antihistamines for allergies
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Acromegaly
Pituitary adenomas and pituitary hyperfunction: Clinical
Protein synthesis inhibitors: Aminoglycosides
Antituberculosis medications
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Miscellaneous protein synthesis inhibitors
Mechanisms of antibiotic resistance
Integrase and entry inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Hepatitis medications
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Neuraminidase inhibitors
Herpesvirus medications
Azoles
Echinocandins
Miscellaneous antifungal medications
Antimalarials
Light microscopy and staining methods
Cardiac muscle histology
Artery and vein histology
Arteriole, venule and capillary histology
Pituitary gland histology
Pancreas histology
Eye and ear histology
Gallbladder histology
Esophagus histology
Small intestine histology
Liver histology
Spleen histology
Lymph node histology
Skeletal muscle histology
Ureter, bladder and urethra histology

Transcript

Watch video only

Uterine stimulants and relaxants, as their names suggest, are medications used to induce or inhibit contractions of the uterus.

Uterine stimulants are also called uterotonics, because they increase the tone of the muscles of the uterus.

They’re mainly used to induce or facilitate labor, to reduce postpartum hemorrhage, and to induce abortion.

Uterine relaxants are also called tocolytics, where ‘toco-’ refers to childbirth, and ‘-lytic’ means to terminate.

They’re used to stop premature labor inorder to give time for the fetal lungs to mature.

So, the uterus is a super important organ in the female body, because not only does it allow the development of the baby during pregnancy, but it also generates the force necessary to push out that tiny human during labor.

This force results from the muscle contractions that take place in the middle layer of the uterus, the myometrium.

The regulation of these muscle contractions happens at the cellular level, and it all comes down to the activity of myosin light-chain kinase by calcium ions.

This enzyme phosphorylates myosin, inducing muscle contraction.

On the other hand, this enzyme can be turned off via phosphorylation by protein kinase A, which causes the muscles to relax.

Now, during labor, uterine contractions become stronger and more frequent.

Normally, this happens at some point when the fetus is considered full term, which means all their organs are functional and it’s able to live outside mommy’s womb. This typically happens between 37 and 42 weeks’ gestation.

Sometimes labor doesn’t start even though it’s been more than 42 weeks. In these cases, it should be induced by the administration of uterine stimulants which include oxytocin, ergonovine, and prostaglandins.

In other situations the baby, the mother, or both, are at risk if the pregnancy continued.

These include fetal growth restriction, isoimmunization, premature rupture of the membranes, pre-eclampsia, or eclampsia.

Uterotonics are also indicated to augment labor when the contractions aren’t strong enough, and they have the added benefit of preventing postpartum hemorrhage by compressing uterine blood vessels. Finally they can be used for therapeutic abortion.

Okay, let’s look at the uterotonics starting with oxytocin.

This medication activates Gq protein coupled receptors, which activates the enzyme phospholipase C - or PLC for short.

PLC then cleaves a phospholipid called phosphatidylinositol 4,5-bisphosphate into inositol trisphosphate and diacylglycerol.

Inositol trisphosphate is soluble and diffuses freely through the cytoplasm and into the endoplasmic reticulum where it opens up calcium channels.

Since the calcium concentration is higher in the endoplasmic reticulum than in the cytoplasm, calcium flows out of the endoplasmic reticulum to the cytoplasm.

Calcium ions then bind to calmodulin and activate myosin light-chain kinase, inducing muscle contraction.

Now, oxytocin is given via intravenous infusion and the main indication is for labor induction. In fact, it’s the drug of choice for this purpose.

But it’s also indicated in facilitation of labor, and to prevent or treat postpartum hemorrhage. In the last case by intramuscular injection.

But oxytocin not only exerts actions on the uterus, which causes some side effects.

On blood vessels, for example, it causes vasodilation, which ultimately leads to hypotension and reflex tachycardia.

Also, oxytocin can activate antidiuretic hormone-receptors on the collecting ducts of the kidneys. Therefore, stimulating water retention.

For this reason, fluids should be carefully administered. Otherwise, they can cause water intoxication, leading to coma, or even death.

On the other hand, in patients who are suffering preeclampsia, or hypertension during pregnancy, and those with cardiac or renal disease, water retention can be an issue, and extra care must be taken.

Finally, a situation called uterine hyperstimulation can occur where uterine contractions are too long, lasting two minutes or more, or too frequent, with five or more in ten minutes.

Uterine hyperstimulation can cause uterine rupture or impaired oxygen delivery to the baby. Which are obviously serious complications. So if this happens, oxytocin administration should be discontinued right away.

Now, moving on to ergonovine, the exact mechanism of action isn’t completely understood, but it certainly stimulates uterine contraction.

Unlike oxytocin ergonovine is only used to prevent or treat postpartum hemorrhage because ergonovine can cause prolonged tetany of the myometrium, so it should not be used for induction or facilitation of labor. It can be given by intramuscular or intravenous injection.

Besides uterine contraction, ergonovine causes vasoconstriction, which increases blood pressure. So, it should be avoided in patients with hypertension.

Also, ergonovine can cause vasospasm of the arteries that perfuse the heart and trigger angina.

Other side effects include nausea, vomiting, blurred vision, and headache.

Okay, so the last type of uterotonic agents are prostaglandins, which include dinoprostone and misoprostol.

They exert their actions by stimulating Gq protein coupled receptors, just like oxytocin.

They’re also used to facilitate labor and to prevent or treat postpartum hemorrhage.

But, dinoprostone and misoprostol are also indicated to induce abortion after the administration of mifepristone or methotrexate. They can be administered orally, vaginally or intracervically.

Some side effects include nausea, vomiting, and diarrhoea, as well as uterine pain, and uterine hyperstimulation.

Finally, dinoprostone causes bronchoconstriction, so it’s contraindicated in patients with asthma.

Let’s switch gears and talk about uterine relaxants or tocolytics.

Sometimes labor begins too early. If this happens before the 37th week of gestation, the fetal organs, especially the lungs, might not be fully developed.

If the baby’s born in this condition, they may not be able to breath, or have other serious complications, like pulmonary hypertension, or intracranial hemorrhage.

So, in this case, labor can be suppressed with uterine relaxants, thus giving the fetus a few more days in the uterus.

During this time, the mother can be given glucocorticoids to stimulate maturation of the fetal lungs.

Uterine relaxants include selective β2-adrenoceptor agonists, calcium channel blockers, cyclooxygenase inhibitors and oxytocin receptor antagonists; and the indication for all of them is the same: prevention or arrest of preterm labor.

Key Takeaways

Uterine stimulants and relaxants are medications used to induce or inhibit contractions of the uterus. Uterine stimulants are also called uterotonics because they increase the tone of the muscles of the uterus. They're mainly used to induce or facilitate labor, reduce postpartum hemorrhage, and induce abortion. Examples of uterine stimulants include oxytocin, ergonovine, and prostaglandins.

Uterine relaxants, on the other hand, decrease the activity of the uterine muscles. They are also called tocolytics, where �toco-' refers to childbirth, and �-lytic' means to terminate. They're used to stop premature labor to give time for the fetal lungs to mature. Examples of uterine relaxants include elective β2-adrenoceptor agonists, calcium channel blockers, cyclooxygenase inhibitors, and oxytocin receptor antagonists.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Postpartum Hemorrhage: Prevention and Treatment" Am Fam Physician (2017)
  5. "A systematic review and network meta-analysis comparing the use of Foley catheters, misoprostol, and dinoprostone for cervical ripening in the induction of labour" BJOG: An International Journal of Obstetrics & Gynaecology (2015)
  6. "Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development" Journal of Visualized Experiments (2018)
  7. "Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis" Cochrane Database of Systematic Reviews (2018)
  8. "Guideline of guidelines: priapism" BJU International (2016)
  9. "Hypoxia-induced force increase (HIFI) is a novel mechanism underlying the strengthening of labor contractions, produced by hypoxic stresses" Proceedings of the National Academy of Sciences (2015)